Author Archives: Anthony Deepak DSouza
Recent Posts
- Avrobio Stopping Its Gene Therapy Program for Fabry Disease
- Fabry International Network Seeks Entries for FIN Award 2022
- Genomic Medicine: Unique Considerations for Rare Disease Clinical Trials
- Managing Fabry Disease Requires Me to Put Mind Over Matter
- Gene Therapy 4D-310 Safe, Restores Gal A Enzyme in 3 Dosed Patients
- Jasper Therapeutics, Avrobio Team Up to Assess JSP191
- ST-920 Gene Therapy Showing Safety, Signs of Efficacy in Trial
- A Closer Look at Gene Therapy
- Gal A Activity Nears Normal in 2nd Man Given FLT190 Gene Therapy
- One-time AVR-RD-01 Gene Therapy Safe Up to 4.5 Years, Trials Report